Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134572) titled 'Clinical study on the effectiveness of sequential teriparatide followed by denosumab and denosumab treatment in reducing the risk of re-fracture in patients with osteoporotic vertebral fractures' on Oct. 16.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Shenzhen Nanshan People's Hospital

Condition: Osteoporotic Vertebral Fracture

Intervention: DMAb group (control group):Denosumab monotherapy (DMAb)

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2024-03-18

Target Sample Size: DMAb group (control group):295;T-DMAB Group (Experimental Group):295;

Coun...